Next Gen Drug Discovery: A Computer-Aided Perspective Crash Course
Next Gen Drug Discovery: A Computer-Aided Perspective Crash Course
Course Description
This comprehensive crash course bridges the gap between traditional pharmacology and the future of Artificial Intelligence (AI) in medicine. You will explore the revolutionary landscape of Computer-Aided Drug Design (CADD), moving from foundational Chemoinformatics to cutting-edge Generative AI for de novo molecular generation. Throughout the program, we dive deep into how Machine Learning (ML) and Deep Learning (DL) algorithms accelerate Target Identification and Lead Optimization, potentially saving billions in R&D costs. By integrating Big Data analytics with structural biology, this course equips you with the predictive power to simulate drug-receptor interactions and forecast ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) profiles with unprecedented accuracy. Whether you are looking to pivot into Bio-IT or enhance your research capabilities, this course provides a high-octane roadmap to the next generation of life-saving therapeutics.
What You'll Learn
The evolution from Structure-Based Drug Design (SBDD) to AI-Driven Drug Discovery (AIDD).
How to utilize AlphaFold and deep learning for protein structure prediction.
Application of Generative Adversarial Networks (GANs) for creating novel chemical structures.
Techniques for Drug Repurposing using network pharmacology and AI.
Real-world case studies of AI-designed drugs currently in clinical trials.
Curriculum
-
Introduction: The Digital Transformation of the Pharmaceutical Industry.
Lesson -
Foundations of CADD: Ligand-based vs. Structure-based approaches.
Lesson -
Chemoinformatics 101: Molecular representations (SMILES, InChI) and databases.
Lesson -
Machine Learning in Pharma: Supervised vs. Unsupervised learning for hit identification.
Lesson -
Deep Learning & Generative Models: RNNs and VAEs for molecular generation.
Lesson -
Molecular Dynamics (MD) Simulations: Studying the physics of drug binding.
Lesson -
Ethical AI & Regulatory Landscape: FDA/EMA perspectives on AI-derived drugs.
Lesson -
Capstone Project: Designing a lead compound for a specific disease target.
Lesson
